[Hopes of high dose-rate radiotherapy]

Charles Fouillade1, Vincent Favaudon1, Marie-Catherine Vozenin2

  • 1PSL research university, institut Curie, CNRS, Inserm, UMR3347, U1021, 91405 Orsay, France; Université Paris Sud, université Paris-Saclay, CNRS, Inserm, UMR 3347, U1021, 91405 Orsay, France.

Bulletin Du Cancer
|March 12, 2017
PubMed

Related Concept Videos